v3.22.2.2
Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Oct. 02, 2022
Oct. 03, 2021
EPS Numerator––Basic        
Income from continuing operations attributable to Pfizer Inc. common shareholders $ 8,630 $ 8,159 $ 26,373 $ 18,834
Discontinued operations––net of tax (21) (13) 4 (248)
Net income attributable to Pfizer Inc. common shareholders 8,608 8,146 26,378 18,586
EPS Numerator––Diluted        
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions 8,630 8,159 26,373 18,834
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions (21) (13) 4 (248)
Net income attributable to Pfizer Inc. common shareholders and assumed conversions $ 8,608 $ 8,146 $ 26,378 $ 18,586
EPS Denominator        
Weighted-average number of common shares outstanding––Basic 5,607 5,609 5,606 5,597
Common-share equivalents: stock options and stock issuable under employee compensation plans (in shares) 111 116 124 91
Weighted-average number of common shares outstanding––Diluted 5,718 5,725 5,729 5,688
Anti-dilutive common stock equivalents (in shares) [1] 3 0 1 3
[1] These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.